Briggs Morrison, Director at Syndax Pharmaceuticals Inc (SNDX), sold 105,710 shares at $21.18 ($2.2M) on 2023-06-09, disclosed to the SEC on 2023-06-09.
Scheduled sale ($2.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.18 | 24,582 | $521K | 23.3% |
| 2 | $21.18 | 24,582 | $521K | 23.3% |
| 3 | $21.18 | 28,273 | $599K | 26.7% |
| 4 | $21.18 | 28,273 | $599K | 26.7% |
| Total | $21.18 avg | 105,710 | $2.2M | 100% |
| Filing → |
| SNDX | SELL | 2023-08-10 | $1.9M | — | Filing → |
| SNDX | SELL | 2023-07-11 | $1.1M | — | Filing → |
| SNDX | SELL | 2023-05-10 | $2.3M | — | Filing → |